Farah Nabil, and Mohammed Saleem. “First-Line FOLFIRINOX Vs Gemcitabine ± Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma: Real-World Treatment Response and Clinicopathologic Predictors from a 2022 Tertiary-Center Cohort”. Middle Eastern Cancer and Oncology Journal 2, no. 2 (April 19, 2026): 11–17. Accessed May 28, 2026. https://scientificsteps-group.com/ojs/ojs3/index.php/mecoj/article/view/191.